Hofseth BioCare ASA 2016 AR2
The report highlights Hofseth BioCare's operations and financial performance for the fiscal year 2016, emphasizing its core value of sustainability and optimal use of marine resources. During the year, the company initiated its 'Turnaround' project, which included upgrading the Midsund factory to produce premium bioactive ingredients like OmeGo, ProGo, CalGo, and PetGo. Hofseth BioCare also achieved FSSC 22000 certification in the fourth quarter of 2016. The company actively worked to reduce its environmental impact, particularly at the Midsund plant, by monitoring emissions and recycling organic waste into biogas.
Company: Hofseth BioCare ASA
Sector: Manufacturing
Country: Norway
Year: 2016
Type: AR2
Pages: 67
Hofseth BioCare ASA
The report highlights Hofseth BioCare's operations and financial performance for the fiscal year 2016, emphasizing its core value of sustainability and optimal use of marine resources. During the year, the company initiated its 'Turnaround' project, which included upgrading the Midsund factory to produce premium bioactive ingredients like OmeGo, ProGo, CalGo, and PetGo. Hofseth BioCare also achieved FSSC 22000 certification in the fourth quarter of 2016. The company actively worked to reduce its environmental impact, particularly at the Midsund plant, by monitoring emissions and recycling organic waste into biogas.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jan 1, 2016 - Dec 31, 2016
Fiscal Year
2016
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Workplace Fatalities
Employees